Related Experiment Video
Updated: Jun 27, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Fibrinaloid Microclots and Atrial Fibrillation
Douglas B Kell1,2,3, Gregory Y H Lip4,5, Etheresia Pretorius1,3
1Department of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, Faculty of Health and Life Sciences, University of Liverpool, Crown St, Liverpool L69 7ZB, UK.
Insights
Fibrinaloid microclots, often found with inflammatory diseases, may contribute to the development of atrial fibrillation (AF). This research suggests microclots could play a causal role in AF, impacting treatment strategies.
Area of Science:
- Cardiology
- Pathology
- Systems Biology
Background:
- Atrial fibrillation (AF) is frequently associated with chronic inflammatory conditions.
- Fibrinaloid microclots are known to accompany these inflammatory diseases and are a consequence of AF.
- The potential causal role of microclots in AF development remains underexplored.
Purpose of the Study:
- To investigate whether fibrinaloid microclots contribute to the etiology of atrial fibrillation.
- To explore the link between known AF risk factors and microclot formation.
- To consider the implications of microclots as a potential cause of AF.
Main Methods:
- Review of existing literature on AF, inflammatory diseases, and microclots.
- Analysis of the role of exogenous stimuli (infection, air pollution) in AF and microclot formation.
- Examination of in vitro data on microclot stimulation by infectious agents (e.g., SARS-CoV-2 spike protein).
Main Results:
- Infections and air pollution, known AF triggers, stimulate fibrinaloid microclots in vitro.
- Fibrinaloid microclots exhibit cytotoxicity, potentially through hypoxia/reperfusion.
- Evidence suggests a plausible etiological role for microclots in AF development.
Conclusions:
- Microclots may be a causative factor or contributor to atrial fibrillation development.
- This hypothesis has significant implications for understanding AF mechanisms.
- Potential for novel therapeutic strategies targeting microclots in AF.
Abstract:
Atrial fibrillation (AF) is a comorbidity of a variety of other chronic, inflammatory diseases for which fibrinaloid microclots are a known accompaniment (and in some cases, a cause, with a mechanistic basis). Clots are, of course, a well-known consequence of atrial fibrillation. We here ask the question whether the fibrinaloid microclots seen in plasma or serum may in fact also be a cause of (or contributor to) the development of AF. We consider known 'risk factors' for AF, and in particular, exogenous stimuli such as infection and air pollution by particulates, both of which are known to cause AF. The external accompaniments of both bacterial (lipopolysaccharide and lipoteichoic acids) and viral (SARS-CoV-2 spike protein) infections are known to stimulate fibrinaloid microclots when added in vitro, and fibrinaloid microclots, as with other amyloid proteins, can be cytotoxic, both by inducing hypoxia/reperfusion and by other means. Strokes and thromboembolisms are also common consequences of AF. Consequently, taking a systems approach, we review the considerable evidence in detail, which leads us to suggest that it is likely that microclots may well have an aetiological role in the development of AF. This has significant mechanistic and therapeutic implications.
Related Concept Videos
Clot Retraction and Fibrinolysis
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Types of Intermediate Filaments

